Daga A, Fabbi M, Mattioni T, Bertolini S, Corte G
Atherosclerosis Prevention Center, University of Genoa, Italy.
Arteriosclerosis. 1988 Nov-Dec;8(6):845-50. doi: 10.1161/01.atv.8.6.845.
Familial hypercholesterolemia is a metabolic disorder inherited as an autosomal dominant trait characterized by an increased plasma low density lipoprotein (LDL) level. It has been demonstrated that the disease is caused by several different mutations in the LDL receptor gene. Although early identification of individuals carrying the defective gene could be useful in reducing the risk of atherosclerosis and myocardial infarction, the available techniques for determining the number of the functional LDL receptor molecules are not sufficiently accurate. The recent isolation of the LDL receptor gene now makes it possible to use restriction fragment length polymorphisms to study the inheritance of the defective allele in families with familial hypercholesterolemia. In the present study, we report the use of a Pvu II restriction fragment length polymorphism to follow the inheritance of familial hypercholesterolemia in a total of 79 patients from 37 different families. This restriction fragment length polymorphism allowed unequivocal diagnosis in 32.5% of the cases. Furthermore, in the Italians studied, the absence of a polymorphic Pvu II cutting site (P1 allele) was found to be strongly associated with familial hypercholesterolemia.
家族性高胆固醇血症是一种作为常染色体显性性状遗传的代谢紊乱疾病,其特征为血浆低密度脂蛋白(LDL)水平升高。已证实该疾病由LDL受体基因中的几种不同突变引起。虽然早期识别携带缺陷基因的个体对于降低动脉粥样硬化和心肌梗死的风险可能有用,但现有的确定功能性LDL受体分子数量的技术不够准确。最近LDL受体基因的分离现在使得利用限制性片段长度多态性来研究家族性高胆固醇血症家族中缺陷等位基因的遗传成为可能。在本研究中,我们报告了使用Pvu II限制性片段长度多态性来追踪来自37个不同家族的总共79例患者中家族性高胆固醇血症的遗传情况。这种限制性片段长度多态性在32.5%的病例中实现了明确诊断。此外,在所研究的意大利人中,发现缺乏多态性Pvu II切割位点(P1等位基因)与家族性高胆固醇血症密切相关。